| Cassidy Lynn Leonard-scott, DO | |
|
6500 Hospital Dr, Hannibal, MO 63401-6890 | |
| (573) 629-3440 | |
| (573) 629-3416 |
| Full Name | Cassidy Lynn Leonard-scott |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 6500 Hospital Dr, Hannibal, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255628335 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 2014012621 (Missouri) | Primary |
| Entity Name | The Curators Of The University Of Missouri |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235126921 PECOS PAC ID: 4486759560 Enrollment ID: O20070418000290 |
News Archive
Cempra, Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced results of its Phase 1 study of intravenous (IV) solithromycin in healthy subjects. The study demonstrated that IV solithromycin was well tolerated, showed a favorable pharmacokinetic profile (PK) and achieved relevant plasma concentrations.
Health and Human Services Secretary Kathleen Sebelius said Thursday "that she would provide $25 million more to help states buy life-saving medications for people with H.I.V. or AIDS. Advocates for patients said the money was not nearly enough to eliminate waiting lists, which have surged to record levels as people have lost health insurance, along with their jobs, and states have cut their budgets. Ms. Sebelius said she was 'reallocating and transferring $25 million in existing resources' to provide medicines for people on waiting lists.
Rutgers scientists have found an efficient way to enhance the nutritional value of corn - the world's largest commodity crop - by inserting a bacterial gene that causes it to produce a key nutrient called methionine, according to a new study.
Diffusion Pharmaceuticals LLC, a biotechnology company developing innovative cancer treatments, today announced that it has successfully completed a Phase I clinical trial of its lead compound trans sodium crocetinate (TSC) in nine patients with newly diagnosed primary brain cancer (glioblastoma or GBM).
Research just published by the Linterman lab shows that the immune system of older mice can be given a helping hand by applying immunology expertise and some genital wart treatment (don't try this at home just yet)!
› Verified 2 days ago
| Entity Name | Hannibal Regional Healthcare System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134311392 PECOS PAC ID: 1254236300 Enrollment ID: O20071004000422 |
News Archive
Cempra, Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced results of its Phase 1 study of intravenous (IV) solithromycin in healthy subjects. The study demonstrated that IV solithromycin was well tolerated, showed a favorable pharmacokinetic profile (PK) and achieved relevant plasma concentrations.
Health and Human Services Secretary Kathleen Sebelius said Thursday "that she would provide $25 million more to help states buy life-saving medications for people with H.I.V. or AIDS. Advocates for patients said the money was not nearly enough to eliminate waiting lists, which have surged to record levels as people have lost health insurance, along with their jobs, and states have cut their budgets. Ms. Sebelius said she was 'reallocating and transferring $25 million in existing resources' to provide medicines for people on waiting lists.
Rutgers scientists have found an efficient way to enhance the nutritional value of corn - the world's largest commodity crop - by inserting a bacterial gene that causes it to produce a key nutrient called methionine, according to a new study.
Diffusion Pharmaceuticals LLC, a biotechnology company developing innovative cancer treatments, today announced that it has successfully completed a Phase I clinical trial of its lead compound trans sodium crocetinate (TSC) in nine patients with newly diagnosed primary brain cancer (glioblastoma or GBM).
Research just published by the Linterman lab shows that the immune system of older mice can be given a helping hand by applying immunology expertise and some genital wart treatment (don't try this at home just yet)!
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cassidy Lynn Leonard-scott, DO Po Box 1239, Hannibal, MO 63401-1239 Ph: (573) 629-3440 | Cassidy Lynn Leonard-scott, DO 6500 Hospital Dr, Hannibal, MO 63401-6890 Ph: (573) 629-3440 |
News Archive
Cempra, Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced results of its Phase 1 study of intravenous (IV) solithromycin in healthy subjects. The study demonstrated that IV solithromycin was well tolerated, showed a favorable pharmacokinetic profile (PK) and achieved relevant plasma concentrations.
Health and Human Services Secretary Kathleen Sebelius said Thursday "that she would provide $25 million more to help states buy life-saving medications for people with H.I.V. or AIDS. Advocates for patients said the money was not nearly enough to eliminate waiting lists, which have surged to record levels as people have lost health insurance, along with their jobs, and states have cut their budgets. Ms. Sebelius said she was 'reallocating and transferring $25 million in existing resources' to provide medicines for people on waiting lists.
Rutgers scientists have found an efficient way to enhance the nutritional value of corn - the world's largest commodity crop - by inserting a bacterial gene that causes it to produce a key nutrient called methionine, according to a new study.
Diffusion Pharmaceuticals LLC, a biotechnology company developing innovative cancer treatments, today announced that it has successfully completed a Phase I clinical trial of its lead compound trans sodium crocetinate (TSC) in nine patients with newly diagnosed primary brain cancer (glioblastoma or GBM).
Research just published by the Linterman lab shows that the immune system of older mice can be given a helping hand by applying immunology expertise and some genital wart treatment (don't try this at home just yet)!
› Verified 2 days ago
Dr. James Keith Mann, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 37 El Rancho Dr, Hannibal, MO 63401 Phone: 573-248-1265 | |
Zach Johnson, D.O. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 100 Medical Dr, Hannibal, MO 63401 Phone: 573-221-5250 Fax: 573-231-3824 | |
Brian T Mcginn, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 100 Medical Dr, Hannibal, MO 63401 Phone: 573-221-5250 Fax: 573-231-3723 | |
Julia Marie Roberts, Pediatrics Medicare: Medicare Enrolled Practice Location: 6500 Hospital Dr, Hannibal, MO 63401 Phone: 573-629-3440 Fax: 573-629-3423 | |
Dr. Barbara A White, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 6500 Hospital Dr, Hannibal, MO 63401 Phone: 573-629-3440 Fax: 573-629-3416 | |
Dr. Dana Anne Frazine, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 100 Medical Dr, Hannibal, MO 63401 Phone: 573-221-5250 Fax: 573-231-3723 |